FAS and congestive heart failure: The downregulation of SREBP1c and its downstream targets in the LC-CHF group aligns with the reductions in FAS and ACC activity observed in our data, further supporting the role of chitosan and fish oil in reducing lipogenesis and lipid accumulation in the liver and adipose tissues.